Publikationen in Zusammenarbeit mit Forschern von Hospital Universitari Germans Trias i Pujol (63)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

  2. Anticoagulation Use and Endovascular Thrombectomy in Patients with Large Core Stroke: A Secondary Analysis of the SELECT2 Trial

    Annals of Neurology, Vol. 96, Núm. 5, pp. 887-894

  3. Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial

    Journal of NeuroInterventional Surgery, pp. 1-8

  4. Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients with Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial

    JAMA Neurology, Vol. 81, Núm. 4, pp. 327-335

  5. Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles

    JAMA, Vol. 331, Núm. 9, pp. 750-763

  6. Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial

    The Lancet, Vol. 403, Núm. 10428, pp. 731-740

2023

  1. Intensive 90-day textile wearable Holter monitoring: an alternative to detect paroxysmal atrial fibrillation in selected patients with cryptogenic stroke

    Heart and Vessels, Vol. 38, Núm. 1, pp. 114-121

  2. Intracranial atherosclerotic plaque enhancement and long-term risk of future strokes: A prospective, longitudinal study

    Journal of Neuroimaging, Vol. 33, Núm. 2, pp. 289-301

  3. Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial

    JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788

  4. Trial of Endovascular Thrombectomy for Large Ischemic Strokes.

    New England Journal of Medicine, Vol. 388, Núm. 14, pp. 1259-1271

2022

  1. Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study

    Neurosurgery, Vol. 90, Núm. 6, pp. 725-733

  3. Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology

    Neurologia, Vol. 37, Núm. 1, pp. 61-72

  4. International controlled study of revascularization and outcomes following COVID-positive mechanical thrombectomy

    European Journal of Neurology, Vol. 29, Núm. 11, pp. 3273-3287

  5. Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International Cohort

    Annals of Neurology, Vol. 92, Núm. 3, pp. 364-378

2021

  1. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry

    International Journal of Stroke, Vol. 16, Núm. 4, pp. 437-447

  2. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

    Stroke, Vol. 52, Núm. 1, pp. 132-141

  3. Global impact of COVID-19 on stroke care

    International Journal of Stroke, Vol. 16, Núm. 5, pp. 573-584

  4. Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution

    Neurologia, Vol. 36, Núm. 5, pp. 377-387

  5. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14